International Conference on Opioids

08/22/2025

⏳ Final 2 Weeks: Earn 9.25 CME/CPE Credits -Advance your knowledge of buprenorphine
+ Get a FREE Bonus: 1-year subscription to Journal of Opioid Management (Over $400 in Bonus Value*)!

REGISTER NOW: https://bit.ly/4mwBkgQ

There are just over TWO weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in buprenorphine education. There are 14 excellent presentations designed for quick learning and retention. Here are a few:

Buprenorphine: Not Just Another Opioid – Understanding the World’s Most Interesting Opioid

Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine / Naloxone for Opioid Use Disorder

Buprenorphine: Opioid Agonist-Antagonist Benefits for Opioid Resistant Pain Uncontrolled By Full-Agonist Opioids during Hematopoietic Stem Cell Transplant for Sickle Cell Disease

Conversion of CII Opioid Medications to Buprenorphine in the Chronic Pain Population – Insights and Clinical Pearls

Clinical Pharmacist with DEA License: Efforts to Increase Access to Buprenorphine in a Veteran Population

Outpatient Cross-Titration to Buprenorphine for Chronic Pain

The “Micro”cosm: Magnifying the Nuance of Low Dose Buprenorphine Inductions

REGISTER NOW TO WATCH THESE PRESENTATIONS + 7 more: https://bit.ly/4mwBkgQ
Whether you’ve started or haven’t registered yet, now is the time to act. *Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME credit by August 31, 2025.

Don't miss this opportunity for convenient learning and CME/CPE credits!

08/15/2025

BUPRENORPHINE EDUCATION
⏳ Final 3 Weeks: Earn 9.25 CME/CPE Credits + Get Over $400 in Bonus Value!

Time is running out! There are just THREE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in BUPRENORPHINE education. Whether you’ve started or haven’t registered yet, now is the time to act. Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME/CPE credit by August 31, 2025. www.bupe2024.com

BUPE2024/2025 features an expert-led lineup of clinical video modules focused on buprenorphine, a medication that remains misunderstood and underutilized despite its proven value in treating opioid use disorder and pain. Learn about office-based induction, best practices for chronic pain, patient case studies, co-management strategies, and more—delivered by respected leaders in addiction medicine, pain management, and primary care. www.bupe2024.com

NOTE: This is a self-funded educational program by the Journal of Opioid Management.

To wrap up this landmark educational initiative, we’re also offering a one-year online subscription to the Journal of Opioid Management (a value of over $400) with every paid registration of just $299. But don’t wait—you must complete your post-test by August 31, 2025, to qualify for both your credits and your bonus subscription.

Register or log in now: www.bupe2024.com

Learn more about Buprenorphine and its use in pain and substance use disorders. Share in the latest research and clinical experience! Cutting-edge information on Buprenorphine and its use in medicine. BUPE2024/2025: Buprenorphine in Medicine is a “virtual conference/resource” for those looking t...

08/11/2025

BUPRENORPHINE EDUCATION
⏳ Final 3 Weeks: Earn 9.25 CME/CPE Credits + Get Over $400 in Bonus Value!

Time is running out! There are just THREE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in BUPRENORPHINE education. Whether you’ve started or haven’t registered yet, now is the time to act. Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME/CPE credit by August 31, 2025. www.bupe2024.com

BUPE2024/2025 features an expert-led lineup of clinical video modules focused on buprenorphine, a medication that remains misunderstood and underutilized despite its proven value in treating opioid use disorder and pain. Learn about office-based induction, best practices for chronic pain, patient case studies, co-management strategies, and more—delivered by respected leaders in addiction medicine, pain management, and primary care. www.bupe2024.com

NOTE: This is a self-funded educational program by the Journal of Opioid Management.

To wrap up this landmark educational initiative, we’re also offering a one-year online subscription to the Journal of Opioid Management (a value of over $400) with every paid registration of just $299. But don’t wait—you must complete your post-test by August 31, 2025, to qualify for both your credits and your bonus subscription.

Register or log in now: www.bupe2024.com

08/01/2025

BUPRENORPHINE EDUCATION
⏳ Final 5 Weeks: Earn 9.25 CME/CPE Credits + Get Over $400 in Bonus Value!

Time is running out! There are just FIVE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in BUPRENORPHINE education. Whether you’ve started or haven’t registered yet, now is the time to act. Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME/CPE credit by August 31, 2025. www.bupe2024.com

BUPE2024/2025 features an expert-led lineup of clinical video modules focused on buprenorphine, a medication that remains misunderstood and underutilized despite its proven value in treating opioid use disorder and pain. Learn about office-based induction, best practices for chronic pain, patient case studies, co-management strategies, and more—delivered by respected leaders in addiction medicine, pain management, and primary care. www.bupe2024.com

To wrap up this landmark educational initiative, we’re also offering a one-year online subscription to the Journal of Opioid Management (a value of over $400) with every paid registration of just $299. But don’t wait—you must complete your post-test by August 31, 2025, to qualify for both your credits and your bonus subscription.

Register or log in now: www.bupe2024.com

Learn more about Buprenorphine and its use in pain and substance use disorders. Share in the latest research and clinical experience! Cutting-edge information on Buprenorphine and its use in medicine. BUPE2024/2025: Buprenorphine in Medicine is a “virtual conference/resource” for those looking t...

05/28/2025

BUPE2024/BUPE2025: Buprenorphine in Medicine is a “virtual conference/resource” for those looking to learn about this exciting molecule and apply it in clinical practice for pain management and addiction medicine. Learn the latest research and practice from experts in the field. www.bupe2025.com

Presentations are available NOW! CMEs and CPEs are available!¹ Plus, attendees will receive a copy of our Journal of Opioid Management special issue on Buprenorphine. It is part of your registration and available for download immediately after you register. www.bupe2025.com

Sign up today at www.bupe2025.com! Take advantage of great content, great presenters, our special issue on buprenorphine and get continuing education credit too!

10/30/2024

🌟 Exciting News for Healthcare Professionals! 🌟

Are you ready to dive deep into the world of buprenorphine? Join us at BUPE2024.com, a unique virtual conference where you can learn everything about buprenorphine from the leaders in the field!

Don’t miss this opportunity to expand your knowledge in opioids, pain management, and addiction medicine. Join the conversation today!

🗣️ Featured Presentation: Don’t miss "The 'Micro'cosm: Magnifying the Nuance of Low Dose Buprenorphine Inductions" by , Clinical Pharmacy Specialist in Pain Management and Substance Use Disorders, alongside , Opioid Stewardship Coordinator at the Hospitality of the University of Pennsylvania. This session promises to enhance your understanding of buprenorphine like never before!

With over 14 presentations and posters, you can learn at your own pace and earn up to 9.25 CME or CPE credits! All this for a registration fee of $299. 📚✨

Learn more about Buprenorphine and its use in pain and substance use disorders. Share in the latest research and clinical experience! Cutting-edge information on Buprenorphine and its use in medicine. BUPE2024: Buprenorphine in Medicine is a “virtual conference/resource” for those looking to lea...